Get App Open
In App
Lending
Lending
Open App

Natco Pharma Ltd.

BSE: 524816 | NSE: NATCOPHARM |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE987B01026 | SECTOR: Pharmaceuticals & Drugs

BSE Live

Dec 05, 16:01
932.50 -16.35 (-1.72%)
Volume
AVERAGE VOLUME
5-Day
262,963
10-Day
356,619
30-Day
159,976
43,801
  • Prev. Close

    948.85

  • Open Price

    947.15

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

NSE Live

Dec 05, 15:59
933.60 -15.65 (-1.65%)
Volume
AVERAGE VOLUME
5-Day
4,065,593
10-Day
4,744,636
30-Day
2,179,446
838,020
  • Prev. Close

    949.25

  • Open Price

    945.00

  • Bid Price (Qty.)

    933.60 (3)

  • Offer Price (Qty.)

    0.00 (0)

Company Facts - N.A.

Registered Address

NATCO House, Road # 2,
Banjara Hills,,
Hyderabad
Telangana
500034

Tel: 040-23547532
Fax: 040-23548243
Email: investors@natcopharma.co.in
Website: http://www.natcopharma.co.in
Group:

Registrars

Venture Capital & Corporate Investments Pvt. Ltd. “Aurum”, Door No.4-50/P-II/57/4F & 5F, Plot No.57,
Hyderabad - 500032
Telangana

Tel: 040-23818475, 23868257, 35164940
Fax:
Email: investor.relations@vccipl.com
Website: https://www.vccipl.com

Management - N.A.

NameDesignation
NameDesignation
Source : Dion Global Solutions Limited
Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347
Close Gen AI Masterclass